Abstract: The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.

Abstract: The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.

Abstract: The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.

Abstract: The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.

Abstract: Disclosed are an intake analysis system and a method thereof comprising an intake sensing device and a cloud computing device. The intake sensing device may be installed in a container containing an ingesta, providing for analyzing a component of the ingesta to generate a detecting signal, and sensing a weight variation of the container having the ingesta therein to generate a weight sensing signal; the cloud computing device receives the detecting signal and weight sensing signal transmitted and calculates a calorie value and an intake value to generate substance ingested information, and compares the calorie value and the intake value. When the calorie value or intake value is greater than a predetermined value respectively, the cloud computing device generates a noticing signal, and transmits the substance ingested information and noticing signal to the intake sensing device, and the intake sensing device displays the substance ingested information and noticing information.

Abstract: The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.

Abstract: The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.

Abstract: The present invention relates generally to a population of cells genetically modified to produce insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells genetically modified to produce insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.

Abstract: A pressure enabling apparatus includes: a pressure sensor, a resistance wire and a pressure setting module, wherein a terminal of the resistance wire is connected to the pressure sensor and another terminal thereof is connected to an electronic apparatus. The pressure setting module is provided for receiving and converting a resistance variation of the resistance wire into a pressure value. The pressure sensor is provided for varying the resistance value thereof according to an external pressure variation, wherein the resistance variation is processed and transmitted to the pressure setting module via the resistance wire. The electronic apparatus implements an application or function according to a pressure value of the pressure setting module. An electronic apparatus is also provided for implementing different applications by pressing the electronic apparatus and for setting numbers or pages when an application of music-playing or document-reading is locked.

Abstract: Disclosed are a mail transit system and a mail recycling correction method. The mail transit system includes a sending-end device and a cloud transit device. The sending-end device is configured to provide a user to send a mail message via a first mail box interface. The cloud transit device is connected to the sending-end device, and configured to receive the mail message, perform address transformation, and transmit the transformed mail message to a second mail box interface. The first mail box interface is different from the second mail box interface, and when the mail message in the second mail box interface is in an unread state, the sending-end device is provided for the user to amend the mail message and send a correction command to the cloud transit device, so as to recycle or amend the mail message at the second mail box interface by the cloud transit device.

Abstract: Disclosed are an intake analysis system and a method thereof comprising an intake sensing device and a cloud computing device. The intake sensing device may be installed in a container containing an ingesta, providing for analyzing a component of the ingesta to generate a detecting signal, and sensing a weight variation of the container having the ingesta therein to generate a weight sensing signal; the cloud computing device receives the detecting signal and weight sensing signal transmitted and calculates a calorie value and an intake value to generate substance ingested information, and compares the calorie value and the intake value. When the calorie value or intake value is greater than a predetermined value respectively, the cloud computing device generates a noticing signal, and transmits the substance ingested information and noticing signal to the intake sensing device, and the intake sensing device displays the substance ingested information and noticing information.

Abstract: The present invention relates generally to a population of cells genetically modified to comprise pancreatic islet glucokinase and capable of producing insulin in a glucose responsive manner and uses thereof. More particularly, the present invention relates to a population of cells so genetically modified capable of producing insulin in response to physiologically relevant levels of glucose and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of therapeutic and prophylactic regimes directed to the treatment of diabetes and/or the amelioration of symptoms associated with diabetes, based on the transplantation of the cells of the present invention into mammals requiring treatment. Also facilitated is the design of in vitro based screening systems for testing the therapeutic effectiveness and/or toxicity of potential adjunctive treatment regimes.

Abstract: A pressure enabling apparatus includes: a pressure sensor, a resistance wire and a pressure setting module, wherein a terminal of the resistance wire is connected to the pressure sensor and another terminal thereof is connected to an electronic apparatus. The pressure setting module is provided for receiving and converting a resistance variation of the resistance wire into a pressure value. The pressure sensor is provided for varying the resistance value thereof according to an external pressure variation, wherein the resistance variation is processed and transmitted to the pressure setting module via the resistance wire. The electronic apparatus implements an application or function according to a pressure value of the pressure setting module. An electronic apparatus is also provided for implementing different applications by pressing the electronic apparatus and for setting numbers or pages when an application of music-playing or document-reading is locked.

Abstract: An imaging device includes a housing, a lens unit, a detection unit, a central processing unit and a driving unit. The lens unit is configured for moving between a first position where the lens unit is received in the housing, and a second position where the lens unit extends from the housing. The detection unit is configured for detecting a current acceleration of the imaging device. The central processing unit is configured for receiving the current acceleration and generating a low driving voltage value if the current acceleration is smaller than a predetermined value and a high driving voltage value if the current acceleration is equal to or greater than the predetermined value. The driving unit is configured for receiving the generated driving voltage value from the central processing unit and retracting the lens unit from the second position to the first position based on the driving voltage.

Abstract: An imaging device includes a housing, a lens unit, a detection unit, a central processing unit and a driving unit. The lens unit is configured for moving between a first position where the lens unit is received in the housing, and a second position where the lens unit extends from the housing. The detection unit is configured for detecting a current acceleration of the imaging device. The central processing unit is configured for receiving the current acceleration and generating a low driving voltage value if the current acceleration is smaller than a predetermined value and a high driving voltage value if the current acceleration is equal to or greater than the predetermined value. The driving unit is configured for receiving the generated driving voltage value from the central processing unit and retracting the lens unit from the second position to the first position based on the driving voltage.

Abstract: A keypad device having a circuit of electrostatic discharge (ESD) protection is disclosed. The circuit has n and m numbers of column conductive lines and row conductive lines formed on the print circuit board wherein at least one column or row conductive line is connected to the ground and the others are, respectively, connected to the data input terminals and data output terminals of the keypad encoder. The intersections between the column (row) line which is grounded and the row (column) lines are designed for those keys, which are readily attacked by ESD such as the side keys.

Abstract: A keypad device having a circuit of electrostatic discharge (ESD) protection is disclosed. The circuit has n and m numbers of column conductive lines and row conductive lines formed on the print circuit board wherein at least one column or row conductive line is connected to the ground and the others are, respectively, connected to the data input terminals and data output terminals of the keypad encoder. The intersections between the column (row) line which is grounded and the row (column) lines are designed for those keys, which are readily attacked by ESD such as the side keys.

Abstract: Synthetic textiles containing a photochromic pigment. The pigments are prepared by encapsulating a photochromic pigment in a thermoplastic polymer having a high melt flow index, mixed with a primary thermoplastic resin, and extruded at a temperature of less than 250.degree. C. through a spinnerette having a diameter of at least 0.3 mm.

Abstract: Synthetic textiles containing a photochromic pigment. The pigments are prepared by encapsulating a photochromic pigment in a thermoplastic polymer having a high melt flow index, mixed with a primary thermoplastic resin, and extruded at a temperature of less than 250.degree. C. through a spinnerette having a diameter of at least 0.3 ml.